The company launched RSViP™, a new artificial intelligence-enabled tool that helps breast screening programs optimize scheduling for women who are at risk for potentially developing breast cancer.
January 31, 2024
The company launched RSViP™, a new artificial intelligence-enabled tool that helps breast screening programs optimize scheduling for women who are at risk for potentially developing breast cancer.